NOV 20, 2020 7:30 AM PST

Cat Parasite Gives Clues on New Drug Targets for Schizophrenia

WRITTEN BY: Annie Lennon

Researchers from the UK and France have discussed a mechanism of action behind the infamous Toxoplasma gondii parasite transferred to humans from cat litter that may lead to the development of new treatments for schizophrenia and other neurological disorders. 

Estimates say that between 30% and 50% of the world’s population is infected with the parasite. While those infected are usually asymptomatic, it is known to cause headaches, confusion, and seizures in others. It is also linked to an increase in the risk of developing schizophrenia and behavioral changes in rodents. 

T. gondii is only able to sexually reproduce in cats. In doing so, it forms cysts that are excreted in the cat’s feces, where they can then enter new hosts via ingestion of anything contaminated by them. This includes water, soil, vegetables, blood transfusions, and mother to fetus. Virtually any warm-blooded animal may be a host.

After being infected, the infection enters a dormant phase within a few weeks, during which it forms cysts in the brain. These cysts remain there for years, where they affect neurotransmitter norepinephrine levels. 

In their new study, the researchers found that the parasite’s ability to reduce norepinephrine disrupts the body’s ability to regulate the immune system. This then leads to an overactive immune response, which may then change the host’s cognitive functions. 

“Our insight connects the two opposing theories for how Toxoplasma alters host behavior and this may apply to other infections of the nervous system,” says Glenn McConkey, one of the researchers behind the paper. “

One school believes that behavior changes are invoked by the immune response to infection and the other that changes are due to altered neurotransmitters.”

The researchers say that their findings will contribute to our understanding of the link between brain inflammation and cognition. As such, they hope that their work will go on to inform the development of antipsychotic treatments. 

 

Sources: Neuroscience NewsTrends in Immunology

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 18, 2021
Drug Discovery & Development
COVID-19 Antibiotic No More Effective than Placebo
JUL 18, 2021
COVID-19 Antibiotic No More Effective than Placebo
Azithromycin, a broad-spectrum antibiotic commonly used to prevent symptoms of COVID-19 in non-hospitalized patients, do ...
AUG 08, 2021
Drug Discovery & Development
Dietary Supplements Treat Genetic Cause of PTSD
AUG 08, 2021
Dietary Supplements Treat Genetic Cause of PTSD
A combination of two natural nutritional supplements, vitamin A and methyl donor S-adenosylmethionine (SAM), can treat P ...
AUG 11, 2021
Neuroscience
Beige Fat Cells Protect the Brain from Dementia
AUG 11, 2021
Beige Fat Cells Protect the Brain from Dementia
‘Beige’ fat reduces inflammation in mouse brains, and may provide protection from dementia. The correspondin ...
AUG 12, 2021
Drug Discovery & Development
Postpartum depression drug works through altering brain waves
AUG 12, 2021
Postpartum depression drug works through altering brain waves
     Postpartum depression is a form of depression that occurs after childbirth. This form of depres ...
AUG 18, 2021
Cannabis Sciences
Cancer Patients Use Less Cannabis than General Public
AUG 18, 2021
Cancer Patients Use Less Cannabis than General Public
Despite increasing legalization for recreational cannabis across the US, cancer patients have largely abstained from usi ...
SEP 14, 2021
Health & Medicine
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
SEP 14, 2021
Graphene-Oxide Based Nanotechnology and Immunology-An Exciting Partnership
As treatments and infection control practices surrounding COVID-19 continue to evolve, nanotechnological solutions are b ...
Loading Comments...